Nasal Allergies (Rhinitis)



Validation of an Allergic Rhinitis Control Test in Children


Condition:   Allergic Rhinitis
Intervention:   Other: Self Questionnaire
Sponsor:   University Hospital, Montpellier
Not yet recruiting - verified March 2017


Efficacy and Safety of So-Cheong-Ryong-Tang on Perennial Allergic Rhinitis


Condition:   Perennial Allergic Rhinitis
Interventions:   Drug: SCRT;   Drug: Placebos
Sponsors:   Kyung Hee University Hospital at Gangdong;   Kyung Hee University Hospital;   Pusan National University Hospital;   Semyung University Affiliated Oriental Medical Hospital;   Dongguk University Ilsan Oriental Hospital
Recruiting - verified March 2017


Cellulose Powder Against Grass Pollen Allergic Rhinitis


Condition:   Allergic Rhinitis
Interventions:   Device: Nasaleze;   Device: Placebo
Sponsors:   Nasaleze International Ltd;   Göteborg University
Completed - verified January 2017


Efficacy and Safety of the Mometasone Nasal Gel in the Treatment of Persistent Allergic Rhinitis


Condition:   Allergic Rhinitis
Interventions:   Drug: EMS Mometasone gel;   Drug: Mometasone spray nasal
Sponsor:   EMS
Not yet recruiting - verified November 2016


Efficacy and Safety of the Mometasone Nasal Gel in the Treatment of Persistent Allergic Rhinitis


Condition:   Allergic Rhinitis
Interventions:   Drug: EMS Mometasone gel;   Drug: Mometasone spray nasal
Sponsor:   EMS
Not yet recruiting - verified November 2016


Validation of an Allergic Rhinitis Control Test in Teenagers


Condition:   Allergic Rhinitis
Intervention:   Other: Self questionnaire for allergic rhinitis control
Sponsor:   University Hospital, Montpellier
Not yet recruiting - verified June 2016


Intralymphatic Immunotherapy for House Dust Mite, Dog, and Cat Allergy Using Tyrosine S® in Allergic Rhinitis


Condition:   Allergic Rhinitis
Interventions:   Biological: ILIT with extract of causal allergen;   Biological: ILIT with normal saline;   Drug: Rescue medication for allergic rhinitis
Sponsors:   Gachon University Gil Medical Center;   Korea Research Foundation
Recruiting - verified July 2016


Nebulized Beclometasone Dipropionate Improves Nasal Patency in Children With Allergic Rhinitis


Condition:   Allergic Rhinitis
Interventions:   Drug: Nasal Beclomethasone Dipropionate;   Drug: CERCHIO 10 mg/ml OS
Sponsor:   Stefania La Grutta, MD
Recruiting - verified March 2017


Efficacy and Safety of Fixed Dose Combination GSP 301 Nasal Spray (NS) in the Treatment of Seasonal Allergic Rhinitis (SAR)


Condition:   Seasonal Allergic Rhinitis
Interventions:   Drug: GSP 301 NS;   Drug: GOM NS;   Drug: GMM-2 NS;   Drug: GSP 301 Placebo NS
Sponsor:   Glenmark Specialty S.A.
Completed - verified March 2017


Quality of Life in Patients With Allergic Rhinitis: Clinical Trial With Bilastine or Loratadine


Condition:   Allergic Rhinitis
Interventions:   Drug: Bilastine;   Drug: Loratadine
Sponsor:   Universidade do Sul de Santa Catarina
Completed - verified May 2017


Evaluating Factors Involved in Dymista's Superior Clinical Efficacy to Fluticasone Propionate in the Treatment of Seasonal Allergic Rhinitis


Condition:   Allergic Rhinitis
Interventions:   Drug: Placebo;   Drug: Fluticasone propionate;   Drug: Fluticasone/Azelastine nasal spray;   Procedure: Nasal Allergen Challenge
Sponsor:   University of Chicago
Recruiting - verified July 2016


Intralymphatic Immunotherapy (ILIT) for House Dust Mite, Cat, and Dog Allergen in Allergic Rhinitis Patients


Condition:   Allergic Rhinitis
Interventions:   Drug: HollisterStier;   Drug: Normal saline
Sponsors:   Gachon University Gil Medical Center;   Thermo Fisher Scientific
Terminated - verified August 2016


Efficacy of a Depigmented Extract of Phleum in Local Allergic Rhinitis


Condition:   Allergic Rhinitis
Interventions:   Biological: DEPIGOID phleum;   Biological: DEPIGOID Placebo
Sponsors:   Plaza del Hospital Civil;   Laboratorios Leti, S.L.
Completed - verified November 2016


A Study of the Efficacy and Safety of Desloratadine (MK-4117) in Japanese Participants With Perennial Allergic Rhinitis (MK-4117-200)


Condition:   Perennial Allergic Rhinitis
Interventions:   Drug: Desloratadine 5 mg;   Drug: Placebo
Sponsor:   Merck Sharp & Dohme Corp.
Completed - verified March 2017


A Study To Assess The Safety And Tolerability Of Different Doses Of PF-06444753 And PF-06444752 In Subjects With Allergic Rhinitis


Condition:   Allergic Rhinitis
Interventions:   Biological: IGE-1;   Biological: IGE-2;   Biological: Saline
Sponsor:   Pfizer
Completed - verified May 2016


A Clinical Trial to Test How Well Two Drugs, QAW039 and Montelukast Work Both Individually and Together, to Target Allergic Rhinitis Using an Environmental Exposure Chamber


Condition:   Allergic Rhinitis
Interventions:   Drug: QAW039;   Drug: Montelukast;   Drug: Placebo
Sponsor:   Novartis Pharmaceuticals
Completed - verified November 2016


A Study to Evaluate the Safety of Combination Montelukast/Loratadine in Mexican Participants With Allergic Rhinitis (MK-0476A-484)


Condition:   Allergic Rhinitis
Interventions:   Drug: Montelukast 10 mg/loratadine 10 mg;   Drug: Placebo
Sponsor:   Merck Sharp & Dohme Corp.
Completed - verified March 2017


A Study to Compare the Efficacy of QAV680 Against Placebo in Treating Seasonal Allergic Rhinitis in an Environmental Exposure Chamber


Condition:   Seasonal Allergic Rhinitis
Interventions:   Drug: QAV680;   Drug: QAV680;   Drug: Mometasone Furoate
Sponsor:   Novartis
Completed - verified November 2016


Onset of Effect of Mometasone Nasal Spray in Induced Allergic Rhinitis (Study P03431)


Condition:   Allergic Rhinitis
Interventions:   Drug: Mometasone;   Drug: Placebo
Sponsor:   Merck Sharp & Dohme Corp.
Completed - verified March 2017


Study of Nasonex in the Relief of Nasal Congestion in Patients With Seasonal Allergic Rhinitis (Study P05529)


Condition:   Allergic Rhinitis
Interventions:   Drug: Mometasone furoate nasal spray (MFNS);   Drug: Matching placebo nasal spray
Sponsor:   Merck Sharp & Dohme Corp.
Completed - verified March 2017


Study of Nasonex in the Relief of Nasal Congestion in Patients With Seasonal Allergic Rhinitis (Study P05528)(COMPLETED)


Condition:   Allergic Rhinitis
Interventions:   Drug: Mometasone furoate nasal spray (MFNS);   Drug: Matching placebo nasal spray
Sponsor:   Merck Sharp & Dohme Corp.
Completed - verified March 2017


Study of Nasonex in the Relief of Nasal Congestion in Patients With Seasonal Allergic Rhinitis (Study P05583)


Condition:   Allergic Rhinitis
Interventions:   Drug: Mometasone furoate nasal spray (MFNS);   Drug: Matching placebo nasal spray
Sponsor:   Merck Sharp & Dohme Corp.
Completed - verified July 2016


An Exploratory Study of the Effects of a Single Dose of QAX576 (an Interleukin-13 Monoclonal Antibody) on Simulated Hayfever


Condition:   Allergic Rhinitis
Interventions:   Drug: QAX576;   Drug: Placebo
Sponsor:   Novartis
Completed - verified February 2017


Study for the Treatment of Persistent Allergic Rhinitis With Desloratadine (Study P04684)


Condition:   Allergic Rhinitis
Interventions:   Drug: 5-mg Desloratadine;   Drug: Placebo tablet
Sponsor:   Merck Sharp & Dohme Corp.
Completed - verified March 2017


Effects Of Single Doses Of GW784568X On Allergic Rhinitis Symptoms In Male Subjects Whilst In An Environmental Chamber


Condition:   Allergic Rhinitis
Intervention:   Drug: GW784568X
Sponsor:   GlaxoSmithKline
Completed - verified January 2017

Refine Your Search Advanced Search